Press Release- Audited Financial Results for the quarter and year ended March 31, 2025
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has released a press statement covering its audited financial results for the fourth quarter (Q4) and the full financial year ending March 31, 2025. The filing is a formal regulatory disclosure submitted to the stock exchanges after the board has approved the final, audited numbers. It signals completion of the annual audit cycle and makes the company's full-year and Q4 performance officially available to investors and analysts. Detailed revenue, profit, margin and segment figures would be in the attached press release and result documents, which are not reproduced in the headline.
This is a routine but important disclosure — shareholders should review the attached audited results to check revenue growth, profitability, margins and any management commentary on the year ahead. The release itself does not move the stock on its own; what matters is how the actual numbers and outlook compare with market expectations.